Journal article
Cell-matrix Interactions of Factor IX (FIX)-engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. Fibrinogen-alginate microcapsules
Abstract
The success of cell microencapsulation technology in tissue engineering and protein delivery applications depends on the viability and functionality of the encapsulated cells, which in turn are dependent upon cell/matrix interactions. In this work, we compared the viability of cord blood-derived mesenchymal stromal cells (CB MSCs), engineered to secrete factor IX (FIX) for hemophilia treatment, and encapsulated in arginine-glycine-aspartate …
Authors
Sayyar B; Dodd M; Marquez-Curtis L; Janowska-Wieczorek A; Hortelano G
Journal
Artificial Cells Nanomedicine and Biotechnology, Vol. 42, No. 2, pp. 102–109
Publisher
Taylor & Francis
Publication Date
April 2014
DOI
10.3109/21691401.2013.794354
ISSN
2169-1401